logo
welcome
ScienceDaily

ScienceDaily

Mpox vaccine is safe and generates a robust antibody response in adolescents, study finds

ScienceDaily
Summary
Nutrition label

86% Informative

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.

Adolescents are among the population groups affected by mpox in the current Clade I mpox outbreak.

The modified vaccinia Ankara-Bavarian Nordic ( MVA-BN ) vaccine is approved in several countries for the prevention of mpox and smallpox in adults.

VR Score

93

Informative language

97

Neutral language

52

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

1

Source diversity

1

Affiliate links

no affiliate links